O
ITMN

OrbiMed’s INTERMUNE INC ITMN Stock Holding History

OrbiMed’s Portfolio ITMN Stock Details ITMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,425,200
Closed -$240M – 154
2014
Q2 		$240M Sell
5,425,200
-526,800
-9% -$19.4M 2.81% 11
2014
Q1 		$199M Sell
5,952,000
-1,745,000
-23% -$38.9M 2.45% 11
2013
Q4 		$113M Buy
7,697,000
+4,809,400
+167% +$66.5M 1.67% 20
2013
Q3 		$44.4M Buy
2,887,600
+2,651,600
+1,124% +$37.2M 0.79% 35
2013
Q2 		$2.27M Buy
+236,000
New +$2.25M 0.05% 119

Other funds holding ITMN

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

OrbiMed's ITMN Position: Q3 2014 in Review

OrbiMed sold out of INTERMUNE INC (ITMN) in Q3 2014, closing a stake of 5,425,200 shares — an estimated $240M sold.

OrbiMed first reported a position in ITMN in Q2 2013 and held it in 5 quarters. The position peaked at $240M in Q2 2014. 22 funds tracked by Wall St. Rank hold ITMN as of Q3 2014.

  • OrbiMed reported no remaining INTERMUNE INC position as of Q3 2014 after selling out during the quarter.
  • OrbiMed sold 5,425,200 INTERMUNE INC shares in Q3 2014, an estimated $240M.
  • OrbiMed first reported a position in INTERMUNE INC in Q2 2013 and held it in 5 quarters.
  • OrbiMed's INTERMUNE INC position peaked at $240M in Q2 2014.
  • 22 funds tracked by Wall St. Rank held INTERMUNE INC as of Q3 2014.

Based on OrbiMed's 13F filing for Q3 2014, filed 14 Nov 2014.